Healthcare: 2 Hot Biotech Stocks On Our Radar
Industry Focus - Ein Podcast von The Motley Fool
Kategorien:
How Regenxbio is capitalizing on the emerging gene therapy trend and why Neurocrine Biosciences is on the cusp of making the jump to profitability. Also, how Amarin may revolutionize how doctors treat heart disease. Stocks: RGNX, NVS, NBIX, ABBV, AMRN.
